![Michael Weiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Weiss
Algemeen Directeur bij
TG THERAPEUTICS, INC.
Vermogen: 377 M $ op 31-05-2026
Profiel
De heer Michael S. Weiss is voorzitter bij Checkpoint Therapeutics, Inc., uitvoerend voorzitter bij Mustang Bio, Inc., partner bij Opus Point Partners Management LLC, partner & portefeuillebeheerder bij Opus Point Partners LLC en uitvoerend voorzitter, president & CEO bij TG Therapeutics, Inc. Hij zetelt in de Raad van Bestuur van Cyprium Therapeutics, Inc., Fortress Biotech, Inc., Caelum Biosciences, Inc., Cellvation, Inc. en Helocyte, Inc. De heer Weiss was voorheen werkzaam als Voorzitter bij National Holdings Corp., niet-uitvoerend Bestuurder bij Avenue Therapeutics, Inc., Co-Voorzitter bij CB Pharma Acquisition Corp., Uitvoerend Voorzitter bij IASO Pharma, Inc., niet-uitvoerend Voorzitter bij National Holdings Corp, voorzitter bij XTL Biopharmaceuticals Ltd., Voorzitter & Chief Executive Officer bij Keryx Biopharmaceuticals, Inc., Voorzitter & Chief Executive Officer bij ACCESS Oncology, Inc., Voorzitter bij Paligent, Inc., Trustee bij Cancer Care, Inc., en Advocaat bij Cravath, Swaine & Moore LLP. Hij was ook lid van de raad van bestuur van Healthcare Integrated Services, Inc. en Genta, Inc. Hij behaalde zijn doctoraal aan de State University of New York in Albany en zijn doctoraal aan de Columbia Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-04-2026 | 9.778.086 ( 6,39% ) | 371 M $ | 31-05-2026 | |
| 16-04-2026 | 2.276.562 ( 6,85% ) | 6 M $ | 31-05-2026 | |
| 18-11-2025 | 325 ( 0% ) | 218 $ | 31-05-2026 |
Actieve functies van Michael Weiss
| Bedrijven | Functie | Begin |
|---|---|---|
| TG THERAPEUTICS, INC. | Algemeen Directeur | 29-12-2011 |
| FORTRESS BIOTECH, INC. | Directeur/Bestuurslid | 20-12-2013 |
| MUSTANG BIO, INC. | Voorzitter | 01-05-2015 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders | Oprichter | 01-01-2017 |
Cellvation, Inc.
 Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Directeur/Bestuurslid | - |
Helocyte, Inc.
 Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Directeur/Bestuurslid | - |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Directeur/Bestuurslid | - |
Eerdere bekende functies van Michael Weiss
| Bedrijven | Functie | Einde |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Algemeen Directeur | 01-12-2016 |
| AVENUE THERAPEUTICS, INC. | Directeur/Bestuurslid | 08-02-2019 |
| ░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Michael Weiss
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
39
Eerstegraads connecties
25
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 25 |
|---|---|
Paligent, Inc.
 Paligent, Inc. Financial ConglomeratesFinance Development stage company | Finance |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
National Holdings Corp.
 National Holdings Corp. Investment Banks/BrokersFinance Operates as a holding company whose subsidiaries provides securities brokerage services | Finance |
Healthcare Integrated Services, Inc.
 Healthcare Integrated Services, Inc. Medical/Nursing ServicesHealth Services Operates fixed-site magnetic resonance imaging centers | Health Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
IASO Pharma, Inc.
 IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
Cravath, Swaine & Moore LLP
 Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance OPPM invests in and assists biotechnology and healthcare companies in developing and commercializing novel medicines and diagnostic tools. | Finance |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origo Acquisition Corp.
 Origo Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Opus Point Partners LLC
 Opus Point Partners LLC Financial ConglomeratesFinance Provides investment services | Finance |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Helocyte, Inc.
Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders | Health Technology |
Cellvation, Inc.
Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Health Technology |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Health Technology |
